ALTIMMUNE, INC. Total Liabilities
ALTIMMUNE, INC. (ALT) had Total Liabilities of $53.00 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-12
- 2026-06-30: Liabilities $53.00M.
- 2026-03-31: Liabilities $51.64M.
- 2025-12-31: Liabilities $55.04M.
- 2025-09-30: Liabilities $32.85M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $53.00M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $51.64M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $55.04M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $32.85M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $28.98M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $15.10M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $15.80M 10-K · filed 2026-03-06 | |
| 2024-09-30 | $14.49M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $20.82M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $15.42M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $16.54M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $16.18M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $15.60M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $19.35M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $21.64M 10-K · filed 2024-03-27 | |
| 2022-09-30 | $20.25M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $15.37M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $20.79M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $19.73M 10-K · filed 2023-02-28 | $19.73M 10-K · filed 2022-03-15 |
| 2021-09-30 | $27.64M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $15.98M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $17.81M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $19.24M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $33.29M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $23.02M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $12.34M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $8.54M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $7.00M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $5.75M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $6.05M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $6.44M 10-K · filed 2020-03-27 | |
| 2018-09-30 | $13.18M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $15.78M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $14.37M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $14.35M 10-K · filed 2019-04-01 | |
| 2017-09-30 | $17.28M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $14.87M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $2.68M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $6.19M 10-K · filed 2018-04-02 | $205.28M 10-K · filed 2017-03-14 |
| 2016-09-30 | $4.16M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $3.68M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $3.11M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $3.21M 10-K · filed 2017-03-14 | |
| 2015-09-30 | $3.22M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $4.28M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $5.44M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $3.70M 10-K · filed 2016-03-11 | |
| 2014-09-30 | $5.24M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $4.36M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $6.05M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $9.80M 10-K · filed 2015-03-11 | |
| 2013-09-30 | $9.27M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $11.37M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $12.03M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $11.07M 10-K · filed 2014-03-11 | |
| 2012-09-30 | $10.86M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $10.26M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $10.98M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $6.95M 10-K · filed 2013-03-14 | |
| 2011-09-30 | $7.10M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $12.24M 10-Q · filed 2011-08-11 | |
| 2010-12-31 | $14.99M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |